Latest News
Jeito Capital (Jeito), an independent Private Equity firm dedicated to biotech and biopharma, has co-led a Series B financing round in SparingVision, a privately held French biotech company.
As a spin-off of the Paris Vision Institute and the result of more than 20 years of scientific research, SparingVision develops genetic innovative therapies in ophthalmology for the treatment of blinding inherited retinal diseases.
Jeito is co-leading this round with the University of Pittsburgh Medical Center Enterprise (UMPCE), and with participation from Ysios Capital, 4Bio, Bpifrance and the RD Fund, the venture arm of Foundation Fighting Blindness (FFB).
Proceeds from the financing
North Island Ventures, a crypto-focused investment firm, has closed NIV Fund II with $125 million in capital commitments. The new fund will aim to make 30 to 40 early-stage investments in emerging crypto and Web3 companies and protocols, with initial investments ranging from $250,000 to $3 million.
NIV Fund II is North Island Ventures’ second new investment vehicle within the past year, bringing the firm’s total assets under management to approximately $300 million.
These funds will support investments in Web3 infrastructure and applications spanning multiple layers, verticals, and use cases, across DeFi, NFTs, digital identity, blockchain cybersecurity, cross-chain interoperability, DeSci, and more.
Apex Group, a global financial services provider, is expanding its business in the Nordics region, with the launch new services delivered from its office in Sweden.
The Securities and Exchange Commission (SEC) has charged registered investment advisers Hudson Advisors and Lone Star Global Acquisitions for including Hudson’s owner’s anticipated income tax liability as a component of certain fees charged to 14 funds they managed.
After raising record levels of venture capital last year, the number of funds doing so this year looks set to plummet. In Q2, global VC fundraising was down year-on-year and the number of funds closed was the lowest seen in the past five years once the Covid-19 panic months of Q2 2020 are excluded, according to Preqin data.
An affiliate of HIG Capital (HIG) has completed the recapitalisation of Navitas Life Sciences (Navitas), a global technology-enabled clinical research organisation (CRO).
Navitas provides outsourced data science (including biostatistics, statistical programming, and data management), regulatory & safety services (including software and monitoring), and other full-service CRO capabilities to blue-chip large and mid-sized pharmaceutical and government clients.
The Company’s functional service expertise optimises the clinical trial process, drives cost efficiencies for its clients, and ensures adherence to regulatory compliance requirements. The Company’s global operations span the United States, India, Europe and South America.
Vista Equity Partners (Vista), a global investment firm focused exclusively on enterprise software, data and technology-enabled businesses, has appointed Michael P Charlton as Managing Director, Capital & Partner Solutions.
Charlton will be responsible for spearheading investor relations efforts dedicated to Vista’s credit platform, Vista Credit Partners and will report to Greg Myers, Senior Managing Director, Global Head of Capital & Partner Solutions.
Charlton brings over three decades of experience leading successful marketing and investor relations initiatives to Vista. He most recently served as Managing Director, Global Head of Business Development and Investor Relations at Anchorage Capital Group. During his tenure,
SER Capital Partners (SER), a private investment firm dedicated to sustainability, has held the final closing of its SER Capital Partners I, LP and affiliated vehicles with $475 million in capital commitments.
The fundraise exceeded SER’s stated target with the support of aligned and well-capitalised limited partners that include a diverse group of leading endowments, state pensions, insurers, health systems and family offices.
\SER invests and enhances value in businesses positioned to meet the growing demand for economic and sustainable assets, products, and services across North America. SER is led by four partners – Rahul Advani, Sara Graziano, Christopher Smith
HarbourVest Partners, a global private markets investment specialist, has appointed Adam Freedman as a managing director and Chief Compliance Officer (CCO).
Freedman has more than 15 years of in-house legal and compliance experience, and most recently he was CCO and Associate General Counsel at Angelo, Gordon & Co. Prior to that role, he was an Executive Director in the Legal and Compliance division at Morgan Stanley.
Freedman received his BA from Yale, his law degree from Oxford, and his Master’s in Law from the University of Chicago.
Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies, has added Ned Leutz as go-to-market lead on the firm’s Growth team.
Leutz will collaborate with other members of the Growth Team to identify and pursue opportunities to enhance value and further scale Great Hill’s portfolio companies.
Leutz is a seasoned executive with over 15 years of experience developing and executing go-to-market strategies, as well as driving top-line revenue and customer growth. LeuHetz is the most recent addition to Great Hill’s Growth Team, which focuses on providing the strategic resources and guidance needed to enhance the growth
Special Reports
Featured
- Partner Content
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
